Oruka Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ORKA and other ETFs, options, and stocks.About ORKA
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002.
CEOLawrence O. Klein
CEOLawrence O. Klein
Employees28
Employees28
HeadquartersMenlo Park, California
HeadquartersMenlo Park, California
Founded
Founded
Employees28
Employees28
ORKA Key Statistics
Market cap1.49B
Market cap1.49B
Price-Earnings ratio-12.76
Price-Earnings ratio-12.76
Dividend yield—
Dividend yield—
Average volume432.68K
Average volume432.68K
High today$31.80
High today$31.80
Low today$30.22
Low today$30.22
Open price$31.44
Open price$31.44
Volume347.93K
Volume347.93K
52 Week high$31.80
52 Week high$31.80
52 Week low$5.49
52 Week low$5.49
Stock Snapshot
With a market cap of 1.49B, Oruka Therapeutics(ORKA) trades at $30.84. The stock has a price-to-earnings ratio of -12.76.
During the trading session on 2025-12-06, Oruka Therapeutics(ORKA) shares reached a daily high of $31.80 and a low of $30.22. At a current price of $30.84, the stock is +2.1% higher than the low and still -3.0% under the high.
Trading activity shows a volume of 347.93K, compared to an average daily volume of 432.68K.
Over the past 52 weeks, Oruka Therapeutics(ORKA) stock has traded between a high of $31.80 and a low of $5.49.
Over the past 52 weeks, Oruka Therapeutics(ORKA) stock has traded between a high of $31.80 and a low of $5.49.
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ORKA. This list is generated using Robinhood data, and it’s not a recommendation.